 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: September 2023
Volume 8 | Issue 9
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 8
Issue Published : 88
Article Submitted : 8769
Article Published : 4490
Total Authors : 11663
Total Reviewer : 551
Total Countries : 86
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A BRIEF CHEMICAL REVIEW OF TRIOXACARCINS: PROMISING ANTICANCER DRUGS |
| Authors Name: | Vinayak Katekar , Sonali Gangurde , Manish Surung , Shruti Adhau |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_185107
|
| Published Paper Id: | IJRTI2301027 |
| Published In: | Volume 8 Issue 1, January-2023 |
| DOI: | |
| Abstract: | Trioxacarcins are polyoxygenated natural compounds with powerful anti-malarial and anti-cancer activities. When trioxacarcins are isolated, six kinds of trioxacarcins are revealed: trioxacarcin A, B, C, D, E, and F. Much important work has been done in the synthesis of trioxacarcins and their derivatives, with an emphasis on step shortness and reaction efficiency. According to the literature, further research is required to formulate and investigate the biological effects of trioxacarcin types D, E, and F. This class is notable for its extraordinary capacity to covalently attach to DNA duplexes, highlighting its potential for gene modification to avoid catastrophic disorders. Every disease has a natural cure, and the trioxacarcins class of medications is a medicinal treasure for cancer complications. |
| Keywords: | cancer, antineoplastic, DNA,, anti-malarial, Trioxacarcins, polyoxygenated. |
| Cite Article: | "A BRIEF CHEMICAL REVIEW OF TRIOXACARCINS: PROMISING ANTICANCER DRUGS", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 1, page no.166 - 176, January-2023, Available :http://www.ijrti.org/papers/IJRTI2301027.pdf |
| Downloads: | 000218 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2301027
Registration ID:185107
Published In: Volume 8 Issue 1, January-2023
DOI (Digital Object Identifier):
Page No: 166 - 176 Country: -, -, - Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2301027 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2301027 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Join RMS/Earn 300
Indexing Partner |
|||
| Copyright © 2023 - All Rights Reserved - IJRTI | |||
Facebook Twitter Instagram LinkedIn